1. Better understanding of the relationship between levodopa pharmacokinetics and pharmacodynamics;
2. Rational therapeutics of parkinson disease using dopaminergic and non-dopaminergic treatments; and
3. Understanding of new levodopa formulations that can help in the management of motor fl uctuations.
11/15/2018 - 7:30am to 8:30am CST
Add to calendar:
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Participation
Peter LeWitt MD